PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	49.02T
Revenue (ttm)	33.38T
Net Income (ttm)	3.41T
Shares Out	45.39B
EPS (ttm)	74.49
PE Ratio	14.50
Forward PE	14.33
Dividend	36.00 (3.33%)
Ex-Dividend Date	Jun 4, 2025

Volume	64,037,200
Average Volume	62,178,515
Open	1,100.00
Previous Close	1,100.00
Day's Range	1,075.00 - 1,115.00
52-Week Range	985.00 - 1,770.00
Beta	-0.04
RSI	29.19
Earnings Date	Oct 30, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.